Personalized Drug Combinations for the Treatment of Acute Myeloid Leukemia (AML) Patients

被引：0
|
作者：
Kang, Yunyi [1 ]
Tran, Trish [1 ]
Zhang, Linda [1 ]
Ball, Edward D. [2 ]
Piermarocchi, Carlo [3 ,4 ]
Paternostro, Giovanni [1 ,4 ]
机构：
[1] Sanford Burnham Med Res Inst, La Jolla, CA USA
[2] Moores UCSD Canc Ctr, La Jolla, CA USA
[3] Michigan State Univ, E Lansing, MI 48824 USA
[4] Salgomed Inc, Del Mar, CA USA
来源：
BLOOD | 2014年 / 124卷 / 21期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Preventive antibiotics in pediatric patients with acute myeloid leukemia (AML)
    Nolt, Dawn
    Lindemulder, Susan
    Meyrowitz, Jeffrey
    Chang, Bill H.
    Malempati, Suman
    Thomas, Gregory
    Stork, Linda
    PEDIATRIC BLOOD & CANCER, 2015, 62 (07) : 1149 - 1154
  • [32] VITAMIN C DEFICIENCY IN PATIENTS WITH ACUTE MYELOID LEUKEMIA (AML)
    Ottone, T.
    Faraoni, I.
    Fucci, G.
    Divona, M.
    De Bellis, E.
    Marchesi, F.
    Angelini, D. F.
    Palmieri, R.
    Gurnari, C.
    Giansanti, M.
    Nardozza, A. M.
    Montesano, F.
    Travaglini, S.
    Puzzangara, M. C.
    De Angelis, G.
    Cicconi, L.
    De Bardi, M.
    Battistini, L.
    Massoud, R.
    Venditti, A.
    Voso, M. T.
    HAEMATOLOGICA, 2021, 106 (10) : 96 - 97
  • [33] Personalized Therapy for Acute Myeloid Leukemia
    Hourigan, Christopher S.
    Karp, Judith E.
    CANCER DISCOVERY, 2013, 3 (12) : 1336 - 1338
  • [34] Cytosine arabinoside, etoposide and aclarubicin (AVA) for the treatment of acute myeloid leukemia (AML) in elderly patients
    Staib, P
    Lathan, B
    Knoppel-Schwark, S
    Tesch, H
    Voliotis, D
    Steinmetz, HT
    Schwonzen, M
    Wickramanayake, PD
    Diehl, V
    ANNALS OF ONCOLOGY, 1998, 9 (02) : 221 - 223
  • [35] Clozapine treatment associated with increased risk of acute myeloid leukemia (AML)
    Nielsen, Jimmi
    Boysen, Anders
    SCHIZOPHRENIA RESEARCH, 2010, 123 (2-3) : 270 - 272
  • [36] Outcomes of Salvage Treatment in Patients with Acute Myeloid Leukemia (AML) with FLT3 Mutations
    Chen, Yiming
    Cortes, Jorge
    Lin, E.
    Ravandi, Farhad
    Faderl, Stefan
    Kadia, Tapan
    Kantarjian, Hagop M.
    Borthakur, Gautam
    BLOOD, 2009, 114 (22) : 820 - 820
  • [37] Gemtuzumab ozogamicin (Mylotarg®) as single agent treatment for adult patients with acute myeloid leukemia (AML).
    Thomas, X
    Le, QH
    Tavernier, E
    Mahmoudi, S
    Chelghoum, Y
    Nicolini, F
    Thiebaut, A
    Troncy, J
    Revesz, D
    Elharmi, M
    Michallet, M
    BLOOD, 2005, 106 (11) : 228B - 229B
  • [38] SYSTEMATIC ASSESSMENT OF HTA DECISIONS FOR PERSONALIZED MEDICINES FOR AN ORPHAN DISEASE: ACUTE MYELOID LEUKEMIA (AML)
    Aggarwal, A.
    Moon, D.
    Kumari, S.
    Sharma, S.
    Bergemann, R.
    VALUE IN HEALTH, 2020, 23 : S6 - S6
  • [39] Targeting LSD1 for acute myeloid leukemia (AML) treatment
    Zhang, Shujing
    Liu, Menghan
    Yao, Yongfang
    Yu, Bin
    Liu, Hongmin
    PHARMACOLOGICAL RESEARCH, 2021, 164
  • [40] Targeted BET protein degradation for the treatment of acute myeloid leukemia (AML) and acute lymphoma leukemia (ALL)
    Hu, Jiantao
    Xu, Fuming
    Fernandez-Salas, Ester
    McEachern, Donna
    Przybranowski, Sally
    Wen, Bo
    Sun, Duxin
    Wang, Shaomeng
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2017, 254
12345